SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-027022
Filing Date
2019-11-08
Accepted
2019-11-08 19:07:33
Documents
1
Period of Report
2019-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7853
  Complete submission text file 0000899243-19-027022.txt   10435
Mailing Address 110 EAST 59TH STREET SUITE 3300 NEW YORK NY 10022
Business Address 110 EAST 59TH STREET SUITE 3300 NEW YORK NY 10022 212-883-0200
RP Management, LLC (Reporting) CIK: 0001507673 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35945 | Film No.: 191205328

Mailing Address 110 E 59TH STREET SUITE 3300 NEW YORK NY 10022
Business Address
Legorreta Pablo G. (Reporting) CIK: 0001507678 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35945 | Film No.: 191205327

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 EAST 59TH STREET SUITE 3300 NEW YORK NY 10022
Business Address 110 EAST 59TH STREET SUITE 3300 NEW YORK NY 10022 212-883-0200
RPI Finance Trust (Reporting) CIK: 0001793690 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35945 | Film No.: 191205329